Patient-reported outcomes validated in phase 3 clinical trials: a targeted literature review
{{output}}
Background: Regulatory guidance advises validation of patient-reported outcome (PRO) instruments prior to use in pivotal clinical studies, which may then be used to generate critical patient-centered evidence and support labellin... ...
